Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PLUR
PLUR logo

PLUR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pluri Inc (PLUR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.320
1 Day change
-1.28%
52 Week Range
5.960
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Pluri Inc (PLUR) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading pre-market at 2.33, down 1.89%, and the technical setup is still bearish. With no strong proprietary buy signal, no recent news catalyst, neutral hedge fund and insider activity, and no clear financial snapshot to support a fundamental thesis, the risk/reward is not attractive for an impatient buyer. I would not buy it now; I would wait for a clearer reversal and stronger confirmation.

Technical Analysis

PLUR's technical picture is weak. MACD histogram is -0.103 and still below zero, showing bearish momentum even though it is contracting. RSI_6 at 22.263 is oversold-like, but it has not yet translated into a confirmed reversal. Moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which confirms the broader downtrend. Pre-market price of 2.33 is below the pivot at 2.863 and close to the first support at 2.298, indicating the stock is still under pressure. The pattern-based trend estimate also leans negative over the next month.

Positive Catalysts

  • No news in the recent week. No recent congress trading data. Hedge funds are neutral and insiders are neutral, so there is no major positive flow-based catalyst. The only mildly supportive point is that RSI is low, which could allow a short-term bounce, but it is not a strong buy signal.

Neutral/Negative Catalysts

  • Pre-market price is down 1.89%. Technical trend is bearish across moving averages and MACD. No AI Stock Picker signal today. No SwingMax signal recently. No recent news catalyst. Hedge fund and insider activity are neutral. Pattern-based outlook suggests downside pressure over the next month.

Financial Performance

Latest quarter financials could not be assessed because the financial snapshot returned an error, so there is no usable recent-quarter seasonal revenue or growth data to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so Wall Street pros' view cannot be confirmed from the available information. Based on the data given, the professional view appears mixed-to-negative because there is no visible upgrade momentum, no target raises, and no supporting catalyst.

Wall Street analysts forecast PLUR stock price to rise
Analyst Rating
0
Wall Street analysts forecast PLUR stock price to rise
Buy
Hold
Sell
0
Current: 2.350
sliders
Low
0
Averages
0
High
0
0
Current: 2.350
sliders
Low
0
Averages
0
High
0
Alliance Global Partners
Matthew Venezia
initiated
$12
AI Analysis
2025-06-02
Reason
Alliance Global Partners
Matthew Venezia
Price Target
$12
AI Analysis
2025-06-02
initiated
Reason
Alliance Global Partners analyst Matthew Venezia re-initiated coverage of Pluri with a Buy rating and $12 price target. The company has transitioned from a clinical-stage cell therapy biotech with some novel bioreactor technology to a diversified biotech applying its "differentiated" bioreactor technology in multiple fields, the analyst tells investors in a research note. The firm says Pluri's bioreactor system which solves many issues with current bioreactors related to scale up and production of cell-based products.

People Also Watch